Oscient Pharmaceuticals Corporation Files Registration Statements for Proposed Exchange Offers with Holders of its Convertible Notes and an Offering of up to $30,000,000 Principal Amount of New 3.50% Convertible Senior Notes due 2011

WALTHAM, Mass.--(BUSINESS WIRE)--Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) today announced that it has filed registration statements with the Securities and Exchange Commission relating to proposed exchange offers involving holders of its outstanding 3½% Senior Convertible Notes due 2011 and 5% Convertible Promissory Notes due 2009 and relating to the sale of additional notes for cash.